Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Conditions: Childhood Cancer; Childhood Solid Tumor; Childhood Brain Tumor; Recurrent Cancer; Refractory Cancer Interventions: Drug: Paxalisib, Irinotecan, Temozolomide; Drug: Pimasertib Sponsors: Australian& New Zealand Children ' s Haematology/Oncology Group; Children ' s Cancer Institute Australia (CCIA); The Hospital for Sick Children; Medical Research Future Fund; Kazia Therapeutics Limited; Day One Biopharmaceuticals, Inc.; C17 Council Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Australia Health | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Cancer in Adolescents | Childhood Cancer | Children | Hospitals | Neurology | New Zealand Health | Research | Temodar